VPS4A
Basic information
Region (hg38): 16:69311336-69326939
Links
Phenotypes
GenCC
Source:
- intellectual disability (Limited), mode of inheritance: AD
- cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome (Strong), mode of inheritance: AD
- cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome (Definitive), mode of inheritance: AD
- cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| CIMDAG syndrome | AD | Hematologic | Among other findings, individuals have been described as having transfusion-dependent anemia, and awareness may allow early diagnosis and medical management | Craniofacial; Hematologic; Musculoskeletal; Neurologic; Ophthalmologic | 33186543; 33186545; 33460484 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (36 variants)
- Inborn_genetic_diseases (31 variants)
- Cerebellar_hypoplasia-intellectual_disability-congenital_microcephaly-dystonia-anemia-growth_retardation_syndrome (13 variants)
- VPS4A-related_disorder (5 variants)
- Syndromic_congenital_hemolytic_and_dyserythropoietic_anemia (3 variants)
- not_specified (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VPS4A gene is commonly pathogenic or not. These statistics are base on transcript: NM_000013245.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | |||||
| missense | 50 | 62 | ||||
| nonsense | 3 | |||||
| start loss | 0 | |||||
| frameshift | 4 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 4 | 2 | 60 | 10 | 3 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| VPS4A | protein_coding | protein_coding | ENST00000254950 | 11 | 13691 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.945 | 0.0553 | 124630 | 0 | 7 | 124637 | 0.0000281 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.69 | 147 | 272 | 0.541 | 0.0000168 | 2851 |
| Missense in Polyphen | 22 | 82.373 | 0.26708 | 835 | ||
| Synonymous | -1.54 | 136 | 115 | 1.18 | 0.00000790 | 836 |
| Loss of Function | 3.79 | 3 | 22.4 | 0.134 | 0.00000120 | 257 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000871 | 0.0000871 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000469 | 0.0000464 |
| European (Non-Finnish) | 0.0000177 | 0.0000177 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000328 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in late steps of the endosomal multivesicular bodies (MVB) pathway. Recognizes membrane-associated ESCRT-III assemblies and catalyzes their disassembly, possibly in combination with membrane fission. Redistributes the ESCRT-III components to the cytoplasm for further rounds of MVB sorting. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. In conjunction with the ESCRT machinery also appears to function in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and enveloped virus budding (HIV-1 and other lentiviruses). Involved in cytokinesis: retained at the midbody by ZFYVE19/ANCHR and CHMP4C until abscission checkpoint signaling is terminated at late cytokinesis. It is then released following dephosphorylation of CHMP4C, leading to abscission (PubMed:24814515). VPS4A/B are required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413). {ECO:0000269|PubMed:11563910, ECO:0000269|PubMed:11595185, ECO:0000269|PubMed:15075231, ECO:0000269|PubMed:22660413, ECO:0000269|PubMed:24814515}.;
- Pathway
- Endocytosis - Homo sapiens (human);Necroptosis - Homo sapiens (human);Ebola Virus Pathway on Host;Ebola Virus Pathway on Host;Disease;Vesicle-mediated transport;Membrane Trafficking;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;Endosomal Sorting Complex Required For Transport (ESCRT);Infectious disease;CXCR4-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.224
Intolerance Scores
- loftool
- 0.197
- rvis_EVS
- -0.85
- rvis_percentile_EVS
- 11.06
Haploinsufficiency Scores
- pHI
- 0.552
- hipred
- Y
- hipred_score
- 0.743
- ghis
- 0.596
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.842
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vps4a
- Phenotype
- immune system phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; embryo phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- actomyosin contractile ring contraction;protein targeting to lysosome;vesicle budding from membrane;nucleus organization;nuclear envelope organization;vacuole organization;mitotic metaphase plate congression;abscission;vesicle-mediated transport;endosomal transport;macroautophagy;viral life cycle;viral release from host cell;nuclear envelope reassembly;intracellular cholesterol transport;negative regulation of cytokinesis;regulation of protein localization;endosomal vesicle fusion;multivesicular body assembly;viral budding via host ESCRT complex;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;mitotic cytokinesis checkpoint;cell division;cytoskeleton-dependent cytokinesis;late endosomal microautophagy;midbody abscission;vesicle uncoating;ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway;positive regulation of viral release from host cell;regulation of protein localization to plasma membrane;positive regulation of exosomal secretion;positive regulation of viral budding via host ESCRT complex;positive regulation of viral life cycle;ESCRT complex disassembly;ESCRT III complex disassembly
- Cellular component
- spindle pole;nucleus;cytoplasm;lysosome;endosome;early endosome;late endosome;vacuolar membrane;centrosome;cytosol;plasma membrane;endosome membrane;midbody;late endosome membrane;perinuclear region of cytoplasm;extracellular exosome;Flemming body
- Molecular function
- protein binding;ATP binding;protein C-terminus binding;ATPase activity;protein domain specific binding;ATPase activity, coupled;protein-containing complex binding